Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

A collaborative effort between IIT Madras and Ohio State University has led to the creation of a pioneering AI framework, PURE, for generating drug-like molecules efficiently. This breakthrough holds ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.

CHENNAI: The researchers from Indian Institute of Technology Madras and The Ohio State University, US, have developed a ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...